Enhanced proliferation of B cells was observed in the RA control group and the number of proliferating B cells (CD20+PCNA+) was significantly lower in the anti-CD154 group than in the control group (Fig. 8A–C). Here, CD40LG is linked to rheumatoid arthritis.